The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to investigate the effects of long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA) on immune function and cardiovascular disease risk
| Condition | Intervention |
|---|---|
|
Cardiovascular Heart Disease Metabolic Syndrome |
Behavioral: Fish oil (Bio-Marine, Pharma Nord) Behavioral: n-6 PUFA intake (Margarine+sunflower oil vs. butter product+rapeseed oil) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Double-Blind Primary Purpose: Prevention |
- Fatty acid composition of PMBC - before and after 2 mo of interventions and after 2 mo of follow-up
- Ex vivo cytokine production (e.g. IL-6, TNF-α, IL-10, and interferon-γ) in whole blood and PBMC cultures after 24 h of stimulation - before and after interventions and after follow up
- Plasma CRP, IL-6 & fibrinogen - before, after and follow-up
- Plasma lipid profile: TAG, cholesterol, LDL & HDL - before, after and follow-up
- Blood pressure - before, after and follow-up
- Anthropometric measures - before, after & follow-up
- Ex vivo cytokine production in isolated monocytes - after intervention only
- Endothelial function (PWV and/or arterial compliance) - before & after
- Superoxide production in full blood samples - before & after
- Plasma insulin/glucose - before, after and follow-up
- Plasma markers of endothelial function (e.g. VCAM-1, ICAM-1, Matrix metallo proteinases, E- & P-selectin, nitrite and endothelin-1) - before and after
- Plasma CD40L - before, after and follow-up
- RBC fatty acid composition - before, after and follow-up
- Coagulation factors (e.g. PAI, tPA, factor VII) - before, after and follow-up
- Folate/homocysteine - before. after and follow-up
- Lipoprotein(a) - before, after and follow-up
| Estimated Enrollment: | 60 |
| Study Start Date: | September 2005 |
| Estimated Study Completion Date: | April 2006 |
In a controlled, double-blinded human intervention study the effects of fish oil versus control (olive oil) and of a high versus low consumption of n-6 polyunsaturated fatty acids are investigated. Sixty-seventy healthy men will be randomized to oil capsules and to substitute their dietary fats with one of two types of oil and butter-product that we provide. Outcome variables are ex vivo cytokine production in full blood and isolated immune cells after 24 h of stimulation with bacteria or bacterial components, blood pressure and arterial function, plasma concentrations of cholesterol, triacylglycerol, C-reactive protein and a number of other markers of endothelial function and cardiovascular risk.
The hypotheses are that both increased intake of n-3 polyunsaturated fatty acids (from fish oil) and a low consumption of n-6 polyunsaturated fatty acids increase incorporation of docosahexanoic acid in immune cell membranes and that this decreases the inflammatory response and potential and improve overall cardiovascular disease risk.
The mechanistic aspects of this will be further explored by in vitro studies with monocytes cultured in the presence of varying amounts of polyunsaturated fatty acids.
Eligibility| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy (no chronic diseases and no regular medications)
- BMI >18.5 and <27.5 kg/m2
- Daily use of fats and home cooking >5 d/wk
- Heavy exercise <7 h/wk
- Not daily smokers (<5 cigarets/wk)
Exclusion Criteria:
Contacts and Locations| Denmark | |
| Department of Human Nutrition | |
| Frederiksberg, Denmark, DK-1958 | |
| Principal Investigator: | Lotte Lauritzen, Ph.D | Department of Human Nutrition, Royal Veterinary and Agricultural University, Denmark |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00266292 History of Changes |
| Other Study ID Numbers: | KF 01 267804, SJVF 23-04-0050, IHE project no. A-304 |
| Study First Received: | December 15, 2005 |
| Last Updated: | May 27, 2010 |
| Health Authority: | Denmark: The Danish National Committee on Biomedical Research Ethics |
Keywords provided by University of Copenhagen:
|
Fish oil Polyunsaturated fatty acid Immune function Endothelial function Cardiovascular risk factors |
Additional relevant MeSH terms:
|
Heart Diseases Metabolic Syndrome X Cardiovascular Diseases Insulin Resistance |
Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases |
ClinicalTrials.gov processed this record on May 19, 2013